The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

Lamb Weston, TJX and AbbVie buck historic market selloff as the Dow Jones Industrial Average falls 1,300 points.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Research analysts at Zacks Research lowered their Q4 2026 EPS estimates for shares of Merck & Co., Inc. in a report released ...

Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of Merck & Co., Inc. in a research note issued to investors on Tuesday, April 1st. Zacks Research analyst S. Ganoria ...

TD Cowen analyst Steve Scala maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of $100.00.

Broad-based skin cancer screening may strain healthcare resources and lead to overdiagnosis, but it may also help catch more ...

The German manufacturer has been exiting heavy-equipment businesses and shifting its focus to software to improve ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

USW Local 10-00086 president said Merck has offered "the worst set of proposals ever" during collective bargaining ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.